Csf3 (GeneID: 12985) | Mus musculus
Description: colony stimulating factor 3 (granulocyte) [Source:MGI Symbol;Acc:MGI:1339751]
Synonyms: Csfg, MGI-IG, G-CSF
Other ID(s): ENSMUSG00000038067, MGI:1339751
Protein Accession Numbers: XP_006532191, NP_034101, XP_030101377
Statistics: ClinVar(5)
ClinVar Pathogenicity of Variations help

∙ Please click the name of species for the protein accession number used in the alignment.
∙ A p letter used as a pointer to positions of post translational modifications in human.
∙ Protein domains illustrated above belong to Homo sapiens (Human).
∙ ClinVar stacked bar chart represents whole protein isoforms of the gene. Please, check the other protein isoforms of the gene below.
∙ If more than one transcripts below are active (with blue background color), it means all the active transcripts have the same sequence.
ENST00000225474 ENST00000331769 ENST00000394148 ENST00000394149 ENST00000577675 ENST00000579852 ENST00000583218 NP_000750 NP_001171618 You are here now! NP_757373 NP_757374


import_contactsClinVar Data
Variation ID filter_list Allele ID filter_list RS Number filter_list Variant Type filter_list Record filter_list Alteration filter_list Clinicial Sig. filter_list Last Update filter_list Phenotypes filter_list Cytogenetic filter_list Review Status filter_list RCV Acc.N. filter_list

healinggnomAD
Variant ID filter_list Transcript ID filter_list Alteration filter_list Annotation filter_list Allele C. filter_list Allele N. filter_list Allele F. filter_list rsNumber filter_list Flagsfilter_list Filter filter_list

placePost-translational Modifications (PTMs)
Gene Name filter_list ACC ID filter_list PTM Type filter_list Position filter_list Mod-rsd filter_list Site +/-7 Aa filter_list Mw_kd filter_list Site grpID filter_list

blur_onCatalogue of Somatic Mutations in Cancer (COSMIC)
Gene Name filter_list Transcript ID filter_list Sample name filter_list Primary Site filter_list Primary Histology filter_list Mutation ID filter_list Mutation CDS filter_list Mutation Aa filter_list Mutation Desc. filter_list FATHMM Prediction filter_list FATHMM Score filter_list Mutation Somatic Status filter_list PUBMED PMID filter_list Tumor Origin filter_list Position filter_list

chrome_reader_modedbSNP
Gene ID filter_list Transcript ID filter_list Consequence filter_list Position filter_list HGVSp filter_list Impact filter_list

format_align_centerProtein Domains (PFAM)
Pfam Domain filter_list Domain Name filter_list Description filter_list Positions filter_list Clan filter_list Clan Name filter_list Organism filter_list
NO RESULT FOUND
PF16647 GCSF Granulocyte colony-stimulating factor 47-195 CL0053 4H_Cytokine Homo sapiens

view_listList of the diseases from DisGeNET
Disease Name filter_list Disease Category filter_list DSI* filter_list DPI** filter_list
Spontaneous abortion Female Urogenital Diseases and Pregnancy Complications ; 0.421 0.828
Abortion, Tubal Female Urogenital Diseases and Pregnancy Complications ; 0.421 0.828
Agranulocytosis Hemic and Lymphatic Diseases ; 0.421 0.828
Anemia Hemic and Lymphatic Diseases ; 0.421 0.828
Aplastic Anemia Hemic and Lymphatic Diseases ; 0.421 0.828
Arthralgia Musculoskeletal Diseases ; Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Malignant neoplasm of urinary bladder Neoplasms ; Male Urogenital Diseases ; Female Urogenital Diseases and Pregnancy Complications ; 0.421 0.828
Bladder Neoplasm Neoplasms ; Male Urogenital Diseases ; Female Urogenital Diseases and Pregnancy Complications ; 0.421 0.828
Malignant neoplasm of breast Neoplasms ; Skin and Connective Tissue Diseases ; 0.421 0.828
Carcinoma Neoplasms ; 0.421 0.828
Malignant neoplasm of skin Neoplasms ; Skin and Connective Tissue Diseases ; 0.421 0.828
Non-Small Cell Lung Carcinoma Neoplasms ; Respiratory Tract Diseases ; 0.421 0.828
Carcinoma, Transitional Cell Neoplasms ; 0.421 0.828
Cardiomyopathy, Dilated Cardiovascular Diseases ; 0.421 0.828
Endogenous depression Mental Disorders ; 0.421 0.828
Depressive disorder Mental Disorders ; 0.421 0.828
Scleroderma Skin and Connective Tissue Diseases ; 0.421 0.828
Diarrhea Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Drug toxicity Chemically-Induced Disorders ; 0.421 0.828
Toxic Epidermal Necrolysis Stomatognathic Diseases ; Skin and Connective Tissue Diseases ; Immune System Diseases ; Chemically-Induced Disorders ; 0.421 0.828
Esophageal Neoplasms Neoplasms ; Digestive System Diseases ; 0.421 0.828
Fever Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Fibrosis Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Gastrointestinal Diseases Digestive System Diseases ; 0.421 0.828
Head and Neck Neoplasms Neoplasms ; 0.421 0.828
Head Neoplasms Neoplasms ; 0.421 0.828
Headache Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Heart Diseases Cardiovascular Diseases ; 0.421 0.828
Heart failure Cardiovascular Diseases ; 0.421 0.828
Congestive heart failure Cardiovascular Diseases ; 0.421 0.828
Hemangiosarcoma Neoplasms ; 0.421 0.828
Hepatic Veno-Occlusive Disease Digestive System Diseases ; Cardiovascular Diseases ; 0.421 0.828
Hepatitis, Toxic Digestive System Diseases ; Chemically-Induced Disorders ; 0.421 0.828
Hodgkin Disease Neoplasms ; Hemic and Lymphatic Diseases ; Immune System Diseases ; 0.421 0.828
Hyperbilirubinemia Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Hypertrophy Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Infarction Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Kidney Diseases Male Urogenital Diseases ; Female Urogenital Diseases and Pregnancy Complications ; 0.421 0.828
Left-Sided Heart Failure Cardiovascular Diseases ; 0.421 0.828
leiomyosarcoma Neoplasms ; 0.421 0.828
Leukemia, Myelocytic, Acute Neoplasms ; 0.421 0.828
Leukopenia Hemic and Lymphatic Diseases ; 0.421 0.828
Liver Cirrhosis, Experimental Digestive System Diseases ; 0.421 0.828
Liver diseases Digestive System Diseases ; 0.421 0.828
Liver neoplasms Neoplasms ; Digestive System Diseases ; 0.421 0.828
Reticulosarcoma Neoplasms ; Hemic and Lymphatic Diseases ; Immune System Diseases ; 0.421 0.828
Lymphoma, Mixed-Cell Neoplasms ; Hemic and Lymphatic Diseases ; Immune System Diseases ; 0.421 0.828
Lymphoma, Non-Hodgkin Neoplasms ; Hemic and Lymphatic Diseases ; Immune System Diseases ; 0.421 0.828
Lymphoma, Undifferentiated Neoplasms ; Hemic and Lymphatic Diseases ; Immune System Diseases ; 0.421 0.828
Melancholia Mental Disorders ; 0.421 0.828
melanoma Neoplasms ; 0.421 0.828
Multiple Myeloma Neoplasms ; Cardiovascular Diseases ; Hemic and Lymphatic Diseases ; Immune System Diseases ; 0.421 0.828
Myopathy Musculoskeletal Diseases ; Nervous System Diseases ; 0.421 0.828
Acute Myeloid Leukemia, M1 Neoplasms ; 0.421 0.828
Neck Neoplasms Neoplasms ; 0.421 0.828
Neoplasm Metastasis Neoplasms ; Pathological Conditions, Signs and Symptoms ; 0.421 0.828
nervous system disorder Nervous System Diseases ; 0.421 0.828
Neutropenia Hemic and Lymphatic Diseases ; 0.421 0.828
Ocular Headache Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Pain Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Pancytopenia Hemic and Lymphatic Diseases ; 0.421 0.828
Peripheral Neuropathy Nervous System Diseases ; 0.421 0.828
Poisoning Chemically-Induced Disorders ; 0.421 0.828
Pulmonary Fibrosis Respiratory Tract Diseases ; 0.421 0.828
Pyemia Bacterial Infections and Mycoses ; Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Localized scleroderma Skin and Connective Tissue Diseases ; 0.421 0.828
Septicemia Bacterial Infections and Mycoses ; Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Skin Neoplasms Neoplasms ; Skin and Connective Tissue Diseases ; 0.421 0.828
Soft Tissue Neoplasms Neoplasms ; 0.421 0.828
Staphylococcal Infections Bacterial Infections and Mycoses ; 0.421 0.828
Stevens-Johnson Syndrome Stomatognathic Diseases ; Skin and Connective Tissue Diseases ; Immune System Diseases ; Chemically-Induced Disorders ; 0.421 0.828
Stomatitis Stomatognathic Diseases ; 0.421 0.828
Thrombocytopenia Hemic and Lymphatic Diseases ; 0.421 0.828
Unipolar Depression Mental Disorders ; 0.421 0.828
Adverse reaction to drug Chemically-Induced Disorders ; 0.421 0.828
Uterine Neoplasms Neoplasms ; Female Urogenital Diseases and Pregnancy Complications ; 0.421 0.828
B-Cell Lymphomas Neoplasms ; Hemic and Lymphatic Diseases ; Immune System Diseases ; 0.421 0.828
High Grade Lymphoma (neoplasm) Neoplasms ; Hemic and Lymphatic Diseases ; Immune System Diseases ; 0.421 0.828
Lymphoma, Intermediate-Grade Neoplasms ; Hemic and Lymphatic Diseases ; Immune System Diseases ; 0.421 0.828
Low Grade Lymphoma (neoplasm) Neoplasms ; Hemic and Lymphatic Diseases ; Immune System Diseases ; 0.421 0.828
Diffuse Mixed-Cell Lymphoma Neoplasms ; Hemic and Lymphatic Diseases ; Immune System Diseases ; 0.421 0.828
Lymphoma, Small Noncleaved-Cell Neoplasms ; Hemic and Lymphatic Diseases ; Immune System Diseases ; 0.421 0.828
Lymphoma, AIDS-Related Neoplasms ; Hemic and Lymphatic Diseases ; Immune System Diseases ; 0.421 0.828
Neoplasms, Second Primary Neoplasms ; 0.421 0.828
Injuries, Acute Brain Nervous System Diseases ; Wounds and Injuries ; 0.421 0.828
Hamman-Rich syndrome Respiratory Tract Diseases ; 0.421 0.828
Depressive Syndrome Mental Disorders ; 0.421 0.828
Liver Dysfunction Digestive System Diseases ; 0.421 0.828
Neoplasms, Therapy-Associated Neoplasms ; 0.421 0.828
Small cell carcinoma of lung Neoplasms ; Respiratory Tract Diseases ; 0.421 0.828
Muscle Weakness Musculoskeletal Diseases ; Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Mixed Cellularity Hodgkin Lymphoma Neoplasms ; Hemic and Lymphatic Diseases ; Immune System Diseases ; 0.421 0.828
Hodgkin lymphoma, lymphocyte depletion Neoplasms ; Hemic and Lymphatic Diseases ; Immune System Diseases ; 0.421 0.828
Uterine Cancer Neoplasms ; Female Urogenital Diseases and Pregnancy Complications ; 0.421 0.828
Polyarthralgia Musculoskeletal Diseases ; Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Liver Failure, Acute Digestive System Diseases ; 0.421 0.828
Hypoplastic anemia Hemic and Lymphatic Diseases ; 0.421 0.828
Anaplastic carcinoma Neoplasms ; 0.421 0.828
Carcinoma, Spindle-Cell Neoplasms ; 0.421 0.828
Undifferentiated carcinoma Neoplasms ; 0.421 0.828
Carcinomatosis Neoplasms ; 0.421 0.828
Leiomyosarcoma, Epithelioid Neoplasms ; 0.421 0.828
Leiomyosarcoma, Myxoid Neoplasms ; 0.421 0.828
Adult Hodgkin Lymphoma Neoplasms ; Hemic and Lymphatic Diseases ; Immune System Diseases ; 0.421 0.828
Pain, Burning Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Ache Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Radiating pain Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Heart Failure, Right-Sided Cardiovascular Diseases ; 0.421 0.828
Ventricular Dysfunction, Left Cardiovascular Diseases ; 0.421 0.828
Sepsis Bacterial Infections and Mycoses ; Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Linear Scleroderma Skin and Connective Tissue Diseases ; 0.421 0.828
Brain Injuries Nervous System Diseases ; Wounds and Injuries ; 0.421 0.828
Brain Lacerations Nervous System Diseases ; Wounds and Injuries ; 0.421 0.828
Malignant Head and Neck Neoplasm Neoplasms ; 0.421 0.828
Depression, Neurotic Mental Disorders ; 0.421 0.828
Bone Marrow Neoplasms Neoplasms ; Hemic and Lymphatic Diseases ; 0.421 0.828
Inflammatory disease of mucous membrane Digestive System Diseases ; Stomatognathic Diseases ; 0.421 0.828
Malignant neoplasm of liver Neoplasms ; Digestive System Diseases ; 0.421 0.828
Throbbing Headache Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Bilateral Headache Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Brain Injuries, Focal Nervous System Diseases ; Wounds and Injuries ; 0.421 0.828
Pain, Splitting Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Pain, Crushing Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Generalized Headache Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Malignant neoplasm of esophagus Neoplasms ; Digestive System Diseases ; 0.421 0.828
Functional Gastrointestinal Disorders Digestive System Diseases ; 0.421 0.828
Breast Carcinoma Neoplasms ; Skin and Connective Tissue Diseases ; 0.421 0.828
Cancer of Neck Neoplasms ; 0.421 0.828
Cancer of Head Neoplasms ; 0.421 0.828
Orthostatic Headache Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Periorbital Headache Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Retro-Ocular Headache Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Sharp Headache Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Vertex Headache Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Pain, Migratory Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Suffering, Physical Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Impairment, Light Touch Sensation Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Pain Sensation Diminished Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Pinprick Sensation Diminished Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Position Sense Disorders Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Proprioceptive Disorders Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Thermal Sensation Disorders Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Somatosensory Disorders Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Drug-Induced Liver Disease Digestive System Diseases ; Chemically-Induced Disorders ; 0.421 0.828
Treatment related secondary malignancy Neoplasms ; 0.421 0.828
Hemicrania Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Upper Aerodigestive Tract Neoplasms Neoplasms ; 0.421 0.828
Mammary Neoplasms, Human Neoplasms ; Skin and Connective Tissue Diseases ; 0.421 0.828
Hepatitis, Drug-Induced Digestive System Diseases ; Chemically-Induced Disorders ; 0.421 0.828
Lymphocyte Rich Classical Hodgkin Lymphoma Neoplasms ; Hemic and Lymphatic Diseases ; Immune System Diseases ; 0.421 0.828
Drug-Induced Stevens Johnson Syndrome Stomatognathic Diseases ; Skin and Connective Tissue Diseases ; Immune System Diseases ; Chemically-Induced Disorders ; 0.421 0.828
Staphylococcus aureus infection Bacterial Infections and Mycoses ; 0.421 0.828
Nodular Lymphocyte Predominant Hodgkin Lymphoma Neoplasms ; Hemic and Lymphatic Diseases ; Immune System Diseases ; 0.421 0.828
Cardiomyopathy, Familial Idiopathic Cardiovascular Diseases ; 0.421 0.828
Mammary Neoplasms Neoplasms ; Skin and Connective Tissue Diseases ; 0.421 0.828
Morphea Skin and Connective Tissue Diseases ; 0.421 0.828
Cholera Infantum Digestive System Diseases ; 0.421 0.828
Oral Mucositis Stomatognathic Diseases ; 0.421 0.828
Cirrhosis Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Severe Sepsis Bacterial Infections and Mycoses ; Pathological Conditions, Signs and Symptoms ; 0.421 0.828
Acute Myeloid Leukemia (AML-M2) Neoplasms ; 0.421 0.828
Myocardial Failure Cardiovascular Diseases ; 0.421 0.828
Heart Decompensation Cardiovascular Diseases ; 0.421 0.828
Drug-Induced Acute Liver Injury Digestive System Diseases ; Chemically-Induced Disorders ; 0.421 0.828
Mycoplasma-Induced Stevens-Johnson Syndrome Stomatognathic Diseases ; Skin and Connective Tissue Diseases ; Immune System Diseases ; Chemically-Induced Disorders ; 0.421 0.828
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum Stomatognathic Diseases ; Skin and Connective Tissue Diseases ; Immune System Diseases ; Chemically-Induced Disorders ; 0.421 0.828
Lymphoma, Diffuse Neoplasms ; Hemic and Lymphatic Diseases ; Immune System Diseases ; 0.421 0.828
Chemical and Drug Induced Liver Injury Digestive System Diseases ; Chemically-Induced Disorders ; 0.421 0.828
Chemically-Induced Liver Toxicity Digestive System Diseases ; Chemically-Induced Disorders ; 0.421 0.828
NO RESULT FOUND
feedback